Biotechnology and Its Applications
This chapter shows how recombinant DNA and tissue-culture technologies are applied in agriculture (GM/Bt crops), medicine (insulin, gene therapy, diagnostics) and transgenic animals, and why such genetic manipulation needs ethical regulation.
Biotechnology is a perennial Prelims favourite — expect direct questions on Bt toxin's mode of action, cry genes, RNAi, golden rice, insulin and gene-therapy firsts, and diagnostics (PCR/ELISA). For Mains it anchors GS-III Science & Technology, feeding debates on GM crops, food and biosafety, IPR and the ethics of genetic engineering. The GEAC angle also links to environmental governance.
Understand the chapter
What Biotechnology Does: The Three Research Areas
Biotechnology is the industrial-scale production of biopharmaceuticals and biologicals using genetically modified microbes, fungi, plants and animals. Its applications span therapeutics, diagnostics, GM crops, processed food, bioremediation, waste treatment and energy. Every biotech process rests on three critical research areas working together.
- Best catalyst: an improved organism (usually a microbe) or a pure enzyme
- Optimal conditions: engineering an environment for the catalyst to act
- Downstream processing: purifying the final protein/organic compound
Tissue Culture and Plant Propagation
When conventional breeding could not keep pace with food demand, tissue culture emerged in the 1950s: whole plants are regenerated from explants grown in sterile nutrient media. This rests on totipotency — the capacity of any cell to form a whole plant. The medium needs a carbon source (sucrose), inorganic salts, vitamins, amino acids and growth regulators (auxins, cytokinins).
- Micropropagation: mass production of plants; products are somaclones (genetically identical)
- Meristem culture: apical/axillary meristem is virus-free, so it yields virus-free plants (banana, sugarcane, potato)
- Somatic hybridisation: fusing naked protoplasts of two varieties gives a somatic hybrid — e.g., pomato (potato + tomato), which was not commercially viable
Genetically Modified Crops and Bt Cotton
GMOs are plants, bacteria, fungi or animals whose genes have been altered. GM crops tolerate abiotic stress, resist pests, cut post-harvest loss, use minerals efficiently and carry better nutrition (golden rice = Vitamin A enriched). Bt cotton is the flagship: the Bt toxin gene from Bacillus thuringiensis is cloned into plants to make a built-in bio-pesticide.
- Bt toxin exists as an inactive protoxin; the alkaline pH of the insect midgut solubilises the crystal and activates it
- Active toxin binds midgut epithelial cells, creates pores, causes swelling, lysis and insect death
- cry genes code the toxins: cryIAc and cryIIAb control cotton bollworm; cryIAb controls corn borer
- Bt toxins are insect-group specific (lepidopterans, coleopterans, dipterans)
RNA Interference for Pest Resistance
RNAi is a natural cellular defence in all eukaryotes that silences a specific mRNA using a complementary double-stranded RNA. It was used to protect tobacco from the root nematode Meloidogyne incognitia. Nematode-specific genes were introduced via Agrobacterium so the host produced both sense and anti-sense RNA, forming dsRNA that silenced the parasite's mRNA.
- dsRNA binds the target mRNA and blocks its translation (silencing)
- Natural sources of such RNA: RNA-genome viruses or transposons
- The parasite cannot survive in a transgenic host expressing the interfering RNA
Biotechnology in Medicine
Recombinant DNA technology mass-produces safe therapeutics that do not trigger the immune reactions common with non-human sources; about 30 recombinant therapeutics are approved worldwide, 12 marketed in India. Genetically engineered insulin, gene therapy and molecular diagnosis are the key applications. Early, pre-symptomatic detection of disease is the medical payoff.
- Insulin: chains A and B linked by disulphide bridges; pro-insulin has an extra C-peptide removed on maturation; Eli Lilly (1983) made both chains in E. coli and joined them
- Gene therapy: a normal gene compensates for a defective one; first done in 1990 on a 4-year-old girl with ADA deficiency using a retroviral vector in lymphocytes
- Molecular diagnosis: PCR amplifies nucleic acid to detect low pathogen loads (HIV, cancer mutations); ELISA uses antigen-antibody interaction
- A radioactive single-strand probe hybridises to complementary DNA; a mutated gene shows no complementarity and is missed on the film
Transgenic Animals
Transgenic animals carry and express an extra foreign gene; over 95 per cent of them are mice. They are created for five broad purposes that range from basic research to industrial production and safety testing. They serve as living models for human disease and as biofactories.
- Normal physiology and development (e.g., insulin-like growth factor)
- Disease models (cancer, cystic fibrosis, rheumatoid arthritis, Alzheimer's) and biological products (alpha-1-antitrypsin for emphysema)
- Rosie (1997), the first transgenic cow, gave human-protein-enriched milk with alpha-lactalbumin at 2.4 g/L
- Vaccine safety (polio testing, replacing monkeys) and chemical/toxicity safety testing
Ethical Issues and Regulation
Unregulated manipulation of living organisms raises moral concerns, and GM organisms can have unpredictable effects when released into ecosystems. Hence India set up a statutory regulatory mechanism for genetic engineering. The nodal body, GEAC, appraises and approves GM research and the commercial release of GMOs.
- GEAC = Genetic Engineering Appraisal Committee — India's nodal approval body for GMOs
- Core concern: ecological unpredictability of releasing GMOs
- Ethics must weigh benefit to humans against harm to other living organisms
Key terms
- Totipotency
- Capacity of any plant cell/explant to regenerate a whole plant under suitable conditions.
- Micropropagation
- Producing thousands of plants in vitro via tissue culture, yielding genetically identical copies.
- Somaclones
- Genetically identical plants produced through micropropagation from a single parent.
- Somatic hybridisation
- Fusing naked protoplasts of two varieties to form a hybrid plant (e.g., pomato).
- GMO
- A plant, bacterium, fungus or animal whose genes have been altered by manipulation.
- Bt toxin
- Insecticidal crystal protein from Bacillus thuringiensis, active only in an insect's alkaline gut.
- cry genes
- Genes coding Bt toxins; specific cry genes target specific pests (e.g., cryIAc for cotton bollworm).
- RNA interference (RNAi)
- Cellular defence that silences a specific mRNA using a complementary double-stranded RNA.
- Gene therapy
- Inserting a normal gene to correct or compensate for a defective gene in a patient/embryo.
- Transgenic animal
- An animal engineered to carry and express an extra foreign gene; mostly mice.
Must-know facts exam-ready
- Tissue culture exploits totipotency; micropropagation yields genetically identical somaclones.
- Meristem (apical/axillary) is virus-free, so meristem culture produces virus-free banana, sugarcane and potato.
- Pomato is a somatic hybrid of potato and tomato made by protoplast fusion, never commercialised.
- Bt toxin from Bacillus thuringiensis is an inactive protoxin activated by the alkaline pH of the insect midgut.
- cryIAc and cryIIAb control cotton bollworm; cryIAb controls corn borer; Bt toxins are insect-group specific.
- Golden rice is Vitamin A (beta-carotene) enriched rice.
- RNAi silenced the nematode Meloidogyne incognitia in tobacco using dsRNA delivered via an Agrobacterium vector.
- Insulin has chains A and B joined by disulphide bridges; pro-insulin carries an extra C-peptide removed on maturation.
- Eli Lilly (1983) produced human insulin chains A and B in E. coli and combined them by disulfide bonds.
- First clinical gene therapy: 1990, a 4-year-old girl with ADA (adenosine deaminase) deficiency, via retroviral vector.
- About 30 recombinant therapeutics are approved worldwide and 12 are marketed in India; over 95% of transgenic animals are mice.
- Rosie (1997) was the first transgenic cow; her milk had human alpha-lactalbumin at 2.4 g/L. India's GM regulator is GEAC.
Timeline
- 1950sScientists learn whole plants can be regenerated from explants — birth of tissue culture/totipotency.
- 1983Eli Lilly produces human insulin by making chains A and B in E. coli.
- 1990First clinical gene therapy administered to a 4-year-old girl with ADA deficiency.
- 1997Rosie, the first transgenic cow, produces human-protein-enriched milk (2.4 g/L).
Memory tricks remember it for good
Traps to avoid
- Somaclones (identical clones from micropropagation) are NOT somatic hybrids (protoplast fusion of two varieties, e.g., pomato) — examiners swap these.
- Bt toxin does not kill its own bacterium because it stays an inactive protoxin; it activates only in the alkaline insect gut — not because the bacterium is 'immune'.
- Do not interchange cry genes: cryIAc/cryIIAb = cotton bollworm, cryIAb = corn borer.
- RNAi (silences mRNA, used against the nematode) is a different mechanism from the Bt toxin (pore-forming, used against insects).
- The first gene therapy (1990) was for ADA deficiency, NOT diabetes; insulin (Eli Lilly, 1983) is rDNA production, not gene therapy.
- PCR detects nucleic acid by amplification, while ELISA detects protein via antigen-antibody binding — different principles; golden rice supplies Vitamin A, not iron or protein.
Exam focus
🧠 Prelims angles
- Bt toxin pathway: inactive protoxin to alkaline-gut activation to midgut pores and lysis.
- cry gene–pest matching (cryIAc/cryIIAb cotton bollworm; cryIAb corn borer) and insect-group specificity.
- RNAi mechanism: dsRNA-mediated mRNA silencing, Agrobacterium vector, nematode Meloidogyne incognitia.
- Insulin facts: A and B chains, disulphide bridges, C-peptide, Eli Lilly and E. coli (1983).
- Diagnostics: PCR (HIV, cancer mutations) versus ELISA (antigen-antibody); probe-autoradiography logic.
- Transgenic firsts and figures: Rosie (1997), over 95% mice, first gene therapy 1990 (ADA).
✍️ Mains angles GS-III
- Are GM crops the answer to India's food and farm-income security?Weigh Bt cotton gains (lower pesticide use, bio-pesticide, higher yield) against biosafety and ecological unpredictability; cite GEAC oversight and the golden-rice nutrition argument.
- How has recombinant DNA technology transformed healthcare?Contrast animal-source versus recombinant insulin (immunogenicity, scalability), and note gene therapy's promise but limited curative permanence.
- Why does genetic engineering need ethical and regulatory oversight?Argue from unpredictable ecosystem effects and morality of manipulating organisms; position GEAC as the institutional safeguard balancing innovation with biosafety.
Last-minute revision tick as you recall
- Totipotency to micropropagation to somaclones (identical); protoplast fusion to somatic hybrid (pomato).
- Meristem culture gives virus-free plants.
- Bt toxin: inactive protoxin activated by alkaline insect gut, then midgut lysis.
- cryIAc/cryIIAb to cotton bollworm; cryIAb to corn borer; golden rice = Vitamin A.
- RNAi: dsRNA silences nematode (Meloidogyne incognitia) mRNA via Agrobacterium in tobacco.
- Insulin: A and B chains, disulphide bridges, C-peptide removed; Eli Lilly 1983 in E. coli.
- Gene therapy 1990, ADA deficiency, retroviral vector in lymphocytes.
- PCR detects HIV/cancer (nucleic acid); ELISA uses antigen-antibody (protein).
- Over 95% transgenic animals are mice; Rosie 1997 (alpha-lactalbumin, 2.4 g/L); India's GM regulator = GEAC.
Distilled from NCERT Class 12 · Biology (Class 12) for UPSC. Always cross-check facts with the original NCERT.